Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
add, admission, aforementioned, antagonist, Apotex, Asia, aspect, auditor, Aurobindo, authoritative, BeiGene, BET, Breckenridge, bromodomain, bulk, Bureau, Canadian, carcinoma, Chicago, colorectal, Columbia, companion, concept, contemporaneously, copayment, count, CTA, dataset, David, dehydrogenase, demethylase, deposit, divestiture, divisional, DLBCL, endothelial, Endowment, England, error, expiry, extinguishment, fedratinib, footnote, futility, GILTI, Hart, Hetero, hypertension, IDHIFA, idiopathic, IMFINZI, incomplete, involuntary, irrespective, ivosidenib, joinder, leveraging, London, mandatorily, mediate, mediation, mg, Minister, Mitchell, Monotherapy, motif, mutual, NASH, Navicixizumab, nonalcoholic, Notch, Notwithstanding, Ontario, Ottawa, ovarian, PCAOB, pembrolizumab, PGR, pleading, Polpharma, polycythemia, President, proof, prorated, proximity, pulmonary, QD, randomized, recast, red, regimen, remeasured, remeasurement, remitted, Rodino, ROR, RORgt, RRMM, scalable, scalp, Shanghai, short, Stationary, stop, systematic, TCR, toll, ultra, undistributed, untaxed, vascular, VEGF, vera, Welfare, wrongdoing, young
Removed:
allege, antisense, Chancery, composed, compute, construction, cooperate, correct, credited, discrete, dismissing, elevated, favorably, fiduciary, Follicular, formed, highlighted, indefinitely, irrevocable, oligonucleotide, Penn, perpetual, petition, plaintiff, predetermined, purportedly, refundable, relation, selectively, steering, supplied, unremitted, vote
Filing tables
Filing exhibits
- 10-K Annual report
- 21.1 Exhibit 21.1 List of Subsidiaries
- 23.1 Exhibit 23.1 Consent of Independent Registered Public Accountant
- 24.1 Exhibit 24.1 Power of Attorney
- 31.1 Exhibit 31.1 Certification of the CEO Section 302
- 31.2 Exhibit 31.2 Certification of the CFO Section 302
- 32.1 Exhibit 32.1 Certification of the CEO Section 906
- 32.2 Exhibit 32.2 Certification of the CFO Section 906
- Download Excel data file
- View Excel data file
Related press release
CELG similar filings
Filing view
External links
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. §1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the accompanying Annual Report on Form 10-K of Celgene Corporation ("the Company") for the year ended December 31, 2017 ("the Periodic Report"), I, Peter N. Kellogg, Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge that the Periodic Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934 and that the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: | February 7, 2018 | /s/ Peter N. Kellogg | ||||
Peter N. Kellogg Executive Vice President Chief Financial Officer (principal financial and accounting officer) | ||||||